Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke

Acta Neurologica Belgica

Volumn 112, Issue 4, 2012, Pages 351-356

  Demir, Recep ^a   Ulvi, Hizir ^a   Özel, Lütfi ^a   Özdemir, Gökhan ^a   Güzelcik, Metin ^b   Aygül, Recep ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Romatem Hospital   (Turkey)

Author keywords

Infarct volume; MMP 9; Severity; Stroke

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE;

AGED; BRAIN; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84870623831     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0067-4     Document Type: Article

References (23)

1. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125.
2. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34: 2165-2172.
3. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ (1995) Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 26: 2120-2126.
4. Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, González MA, Monasterio J (2001) Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32: 1759-1766.
5. Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, Monasterio J (2001) Matrix metalloproteinase (MMP-9) expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32: 2762-2767.
6. Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabín J (2003) Matrix metalloproteinase (MMP-9) pre-treatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107: 598-603.
7. Ramos-Fernandez M, Fernanda Bellolio M, Stead LG (2011) Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 20: 47-54.
8. Montaner J, Perea-Gainza M, Delgado P et al (2008) Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39: 2280-2287.
9. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ (1999) Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke 30: 1208-1212.
10. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
11. Michel RP, Cruz-Orive LM (1988) Application of the Cavalieri principle and vertical sections method to lung. Estimation of volume and pleural surface area. J Microsc 150: 117-136.
12. Mun-Bryce S, Rosenberg GA (1998) Matriks metalloproteinases in cerebrovasculer disease (Review). J Cereb Blood Metab 18: 1163-1172.
13. Romanic AM, Write RF, Arteth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemic in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030.
14. Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739: 88-96.
15. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH (1999) Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemic and reperfusion. Brain Res 842: 92-100.
16. Rosenberg GA, Navratil M (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48: 921-926.
17. Kim SC, Singh M, Huang J et al (1997) Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 41: 642-666.
18. Rosenberg GA, Dencoff JE, Correa N, Reiners M, Ford CC (1996) Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46: 1626-1632.
19. Rosell A, Ortega-Aznar A, Alvarez-Sabin J et al (2006) İncreased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37: 1399-1406.
20. Lee SR, Tsuji K, Lo EH (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24: 671-678.
21. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA (2001) Effect of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21: 7724-7732.
22. Rosell A, Alvarez-Sabin J, Arenillas JF, Rovira A, Delgado P, Fernandez-Cadenas I (2005) A matrix metalloproteinase proteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 36: 1415-1420.
23. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribo M, Chacon P (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23: 1403-1407.